Rafarma Pharmaceuticals, Inc. (RAFA)
USD 0.11
(-23.17%)
USD 0.11
(-23.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -50.67 Million | 18.76 Million | 2.87 Million | -8.76 Million | 10.21 Million | -75.39 Thousand |
| Net Income | 273 Thousand | 4.96 Million | 11.57 Million | 14.84 Million | 3.05 Million | -6179.00 |
| Depreciation & Amortization | - | - | - | - | 466 Thousand | - |
| Deferred income taxes | -87 Thousand | -1.26 Million | -3.01 Million | -3.31 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 18.23 Million | 5.7 Million | 2.88 Million | -299 Thousand | 6.69 Million | -69.21 Thousand |
| Other non-cash items | -86.71 Million | 2.99 Million | -12.56 Million | -17 Million | 4.86 Million | 125.25 Thousand |
| Investing Cash Flow | 32.9 Million | -11.72 Million | 6.86 Million | 7.96 Million | -9.34 Million | 335.00 |
| Investments in PPE | 50.67 Million | -12.08 Million | - | - | -11.29 Million | - |
| Acquisitions | 32.9 Million | 355 Thousand | 6.96 Million | 7.96 Million | - | - |
| Investment purchases | - | - | - | - | -3.61 Million | -186.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 1000.00 | -100 Thousand | -1000.00 | 5.57 Million | 521.00 |
| Financing Cash Flow | -197 Thousand | -2.59 Million | -5.28 Million | 2.93 Million | -32.91 Thousand | 85.61 Thousand |
| Debt repayment | -909 Thousand | -791 Thousand | -1.95 Million | -450 Thousand | -16.21 Thousand | -8170.00 |
| Dividends payments | - | - | -3.42 Million | -5.14 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | -16.7 Thousand | 77.44 Thousand |
| Other Financing Activities | 712 Thousand | -1.79 Million | 96 Thousand | 568 Thousand | - | 16.34 Thousand |
| Accounts receivables | 13.72 Million | 4.8 Million | -3.41 Million | -7.22 Million | -308.81 Thousand | -85.47 Thousand |
| Accounts payables | -15.61 Million | -45 Thousand | -275 Thousand | 725 Thousand | - | - |
| Inventory | 19.51 Million | 1.61 Million | 7.68 Million | 3.51 Million | -3.62 Million | -39.78 Thousand |
| Other working capital | 610 Thousand | -665 Thousand | -1.11 Million | 2.68 Million | 10.62 Million | 56.04 Thousand |
| Cash at beginning of period | 18.04 Million | 13.59 Million | 5.44 Million | 845.87 Thousand | 10.72 Thousand | 162.00 |
| Cash at end of period | 82 Thousand | 18.04 Million | 13.59 Million | 5.44 Million | 845.87 Thousand | 10.72 Thousand |
| Capital Expenditure | 50.67 Million | -12.08 Million | - | - | -11.29 Million | - |
| Effect of forex changes on cash | - | -1000.00 | 3.7 Million | 2.46 Million | - | - |
| Net cash flow / Change in cash | -17.96 Million | 4.45 Million | 8.15 Million | 4.59 Million | 835.15 Thousand | 10.56 Thousand |
| Free Cash Flow | - | 6.68 Million | 2.87 Million | -8.76 Million | -1.08 Million | -75.39 Thousand |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 17 Thousand | 34 Thousand | 273 Thousand | -856 Thousand | 1.77 Million | 27 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | -87 Thousand | 173 Thousand | -399 Thousand | -78 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -612 Thousand | 215 Thousand | 18.23 Million | -800 Thousand | 2.04 Million | 953 Thousand |
| Other non-cash items | 255 Thousand | -284 Thousand | -86.71 Million | -6.05 Million | -9.84 Million | -7.15 Million |
| Investing Cash Flow | 1000.00 | 2000.00 | 32.9 Million | 2.58 Million | 1.56 Million | 3.19 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | 1000.00 | 2000.00 | 32.9 Million | 2.98 Million | 1.16 Million | 3.19 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -399 Thousand | 399 Thousand | - |
| Financing Cash Flow | - | - | -197 Thousand | 212 Thousand | 1.6 Million | -39 Thousand |
| Debt repayment | - | - | -909 Thousand | -188 Thousand | -1.18 Million | -102 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 712 Thousand | 25 Thousand | 419 Thousand | 62 Thousand |
| Accounts receivables | -3.16 Million | 138 Thousand | 13.72 Million | -2.2 Million | 1.41 Million | 1.98 Million |
| Accounts payables | 3.87 Million | -6000.00 | -15.61 Million | -270 Thousand | -2.29 Million | -3.93 Million |
| Inventory | -1.23 Million | 83 Thousand | 19.51 Million | 1.51 Million | 2.96 Million | 2.15 Million |
| Other working capital | -91 Thousand | - | 610 Thousand | 166 Thousand | -25 Thousand | 750 Thousand |
| Cash at beginning of period | 66 Thousand | 8.27 Million | 18.04 Million | 13.97 Million | 15.15 Million | 18.04 Million |
| Cash at end of period | 73 Thousand | 66 Thousand | 82 Thousand | 8.27 Million | 13.97 Million | 15.15 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | -2000.00 | -1000.00 | 1000.00 |
| Net cash flow / Change in cash | 7000.00 | -8.2 Million | -17.96 Million | -5.7 Million | -1.18 Million | -2.88 Million |
| Free Cash Flow | -860 Thousand | 180 Thousand | -50.67 Million | -8.5 Million | -4.34 Million | -6.04 Million |
SHESHAINDS
ELT
7987
BEEYU
JTBK
DIVISLAB